Background: The partial edentulous posterior mandible is often a challenge area that requires a
| I NTR OD U CTI ON
Alveolar atrophy is a pathological condition characterized by moderate or severe resorption of alveolar bone due to tooth loss. 1, 2 The loss of teeth determines the loss of the functional stimulus for the alveolar bone. Consequently, the bone undergoes constant and predictable resorption, which differs depending on location: in the mandible, it is primarily horizontal; in interforaminal regions, it is centripetal; however, it is vertical and centrifugal in retroforaminal areas. 3, 4 Alveolar bone resorption and the presence of the inferior alveolar nerve (IAN) make the posterior regions of the mandible the most challenging to treat using osseointegrated implants. 5 Bone-augmentation techniques proposed to increase bone volume in the posterior regions of the mandible include bone grafts (inlay and onlay), osseodistraction, transposition of the IAN, titanium mesh, and guided bone regeneration (GBR). 6 In the last 10 years, short-and long-term studies have demonstrated that GBR is a successful and reliable technique for vertical and horizontal ridge augmentation. 5, [7] [8] [9] [10] [11] GBR can be achieved with two different approaches: application of either a polytetrafluoroethylene (PTFE) titanium-reinforced membrane (ie, a non-resorbable membrane)
or a collagen membrane (ie, a resorbable membrane). 7, [12] [13] [14] [15] To achieve vertical bone augmentation, a resorbable membrane must be supported by a space-making device, such as a titanium mesh (Ti mesh) or a titanium osteosynthesis plate. 14, 15 However, the use of a barrier device is a technique-sensitive procedure that is not free of complications. The main cause of GBR failure is related to early or late exposure of a barrier device, leading to contamination and infection of the biomaterial, irreversibly compromising bone regeneration. [16] [17] [18] [19] In this randomized clinical trial, we sought to evaluate complication rates and vertical bone gain (VBG) after GBR with dense PTFE titanium-reinforced membranes versus with titanium mesh covered with cross-linked collagen membranes.
| M AT ER I AL A N D M E TH ODS
This study was designed as a pilot, parallel-group, double-blind, 
| Study design and patient selection
The study included 40 (2) a vertical peri-implant bone defect of 2 mm in the alveolar ridge that must be regenerated after placement of implants in a threedimensional "ideal" position; (3) capacity to understand and accept the conditions of the study; and 4 continuing participation in the study for at least 1 year of follow up.
The exclusion criteria were as follows: (1) We planned to treat 40 patients; they were randomized into two study groups, depending on a previous computer-generated randomization sequence. Group A included 20 patients treated by means of a dense PTFE (d-PTFE) titanium-reinforced membrane, and Group B included 20 patients treated by means of a titanium mesh (Ti mesh) and cross-linked collagen membrane.
Patients who met the inclusion criteria were informed about the objectives and conditions of the study. Each patient received written information and provided written informed consent before participation in any study-related procedure. After enrollment, each patient received a unique identification number, according to which all data were recorded.
Patient was blinded and did not know the assigned study group.
| Clinical procedures
Following selection, all patient data (ie, personal, medical, and diagnostic data) were recorded on a specific data collection form (CRF), which was completed on each day of monitoring. Prior to surgery, all patients were evaluated and treated for periodontal and dental health and received oral hygiene instructions. All patients received prophylactic antibiotic therapy with 2 g of amoxicillin and clavulanic acid (or 600 mg of clindamycin in cases of penicillin allergies) and anti-inflammatory therapy with 100 mg of nimesulide 1 h before treatment (or 600 mg of Ibuprofen in cases of nimesulide allergies).
Surgical and prosthetic protocol
On the day of the implant and reconstructive surgery (T0), local anesthesia was administered: articaine 4% with epinephrine 1:100.000. A mid-crestal horizontal incision within the keratinized tissue of the edentulous ridge was extended distally to the external oblique ridge of the mandibular ramus. To preserve the lingual nerve when approaching the third molar area, the incision was inclined at 458 in the buccal direction, using the external oblique ridge as a reference line. The midcrestal horizontal incision was extended mesially on the gingival sulcus of the two adjacent teeth, forming two vertical incisions on the buccal and lingual sides. Taking care to avoid flap laceration or perforation, we elevated a full-thickness surgical flap buccally and lingually; the mental nerve was gently isolated, and the mental foramen was exposed.
Because careful management of the soft tissue was important for obtaining and maintaining primary closure of the surgical flap above the area of bone regeneration, particular care was taken to passivate Implant sites were prepared according to the manufacturer's protocol, using twisted drills and/or piezoelectric inserts to complete implant sites, depending on proximity to the IAN. Subsequently, tapered implants were inserted in the corresponding sites until achieving the optimal position (ie, the implant platform was 3 mm apical to the gingival margin of the two adjacent teeth, independent of alveolar ridge levels). Thus, the most coronal portion of the implants was left to protrude from the alveolar ridge, showing the amount of planned vertical bone regeneration. Because the implants protruded coronally over the alveolar ridge level, the vertical bone peri-implant defect could be measured accurately due to vertical and horizontal bone resorption.
After implant placement, the cortical bone of the mandible was perforated repeatedly to reach the bone marrow to promote the migration of osteogenic cells and osteoprogenitor stem cells and the formation of coagulum under the barrier device.
Additionally, 0.5-1.0 g of autogenous bone was harvested from the external oblique ridge of the mandibular ramus using a bone scraper (Safescraper, Meta, RE, Italy); grafting material for bone regeneration was prepared by mixing 50% autogenous bone and 50% bone allograft (EnCore, Osteogenics Biomedical, Lubbock, Texas).
At this point, the randomization envelope was opened, and the assigned treatment was revealed to the surgeon: a d-PTFE titaniumreinforced membrane (Cytoplast Ti-250XL; Osteogenics Biomedical) was used in Group A, whereas a Ti mesh (Trinon Titanium; Karlsruhe, Germany) and cross-linked collagen membrane (Osseoguard, Zimmer Biomet, Warsaw, Indiana) were used in Group B.
The d-PTFE membrane or Ti mesh was modeled and adapted to maintain a three-dimensional space for bone regeneration. First, it was fixed on the lingual side using two or more titanium mini-screws. Then, the grafting material, consisting of a 50:50 mixture of bone allograft and autogenous bone, was carefully positioned around the implants to restore, vertically and horizontally, the peri-implant bone defect.
Finally, the d-PTFE membrane or Ti mesh was fixed definitively on the buccal side using two or more titanium mini-screws. The collagen membrane was applied over the Ti mesh, according to the principles of guided bone regeneration (GBR).
After evidence that the surgical flaps could advance coronally without tension to cover the augmented area, a double suture (Cytoplast PTFE suture; Osteogenics Biomedical) was used to ensure primary closure of the surgical wound. Horizontal mattress sutures were used for flap overlapping, whereas multiple interrupted sutures were used for hermetic closure of the flaps. 12, 13, 20, 24, 25 Antibiotic therapy was prescribed to reduce the risk of infections:
amoxicillin plus clavulanic acid (Augmentin; GlaxoSmithKline, Verona, Italy) at 3 g/day for 7 days or clindamycin (Dalacin; Pfizer srl, Italy)
at 600 mg/day for 6 days (in penicillin-allergic patients). Antiinflammatory therapy with NSAIDs was also recommended: nimesulide (Aulin; Helsinn Birex Pharmaceuticals Ltd., Dublin, Ireland) at 200 mg/ day for 3 days and 100 mg/day for 3 more days or ibuprofen (Brufen;
Gekofar, Milan, Italy) at 1800 mg/day for 3 days and 1200 mg/day for 3 more days (in nimesulide-allergic patients).
For the first 15 days, patients were instructed to consume a fluid diet, whereas patients were instructed to consume a soft diet and to exercise good oral hygiene for the next 15 days. We also recommended three 2-min treatments of chlorhexidine 0.2% (Curasept ADS;
Curaden Healthcare srl, Varese, Italy) each day. Sutures were removed 15 days after surgery.
On the day of the reopening surgery (T1), after 9 months of submerged healing, a mid-crestal horizontal incision within the keratinized tissue was performed without vertical incisions to remove the barrier devices and the mini-screws, to measure the vertical peri-implant bone gain around each implant, and to expose the submerged implants using healing screws. Moreover, a connective tissue graft was performed on the buccal side to increase the thickness of the peri-implant soft tissues.
On the day of functional loading (T2), 2-3 months after reopening surgery, the implant-supported fixed metal-ceramic restorations were delivered to the patients. All definitive restorations were placed in occlusion, where the occlusal surface was thoroughly modeled so that it was in contact with reduced areas during laterality and protrusion excursions, to reduce the dislocating vectorial components; more contacts were maintained in maximum intercuspidation. were recorded on a specific data collection form (CRF), which was completed on each day of intervention or monitoring. All data were collected by a blinded examiner.
Implant stability
Implant stability was evaluated with two different methods: insertion torque (IT, expressed in Ncm) and resonance frequency analysis (RFA, expressed in ISQ). IT was measured with a manual dynamometric torque wrench, able to measure torques up to 100 Ncm. RFA was used to measure the implant stability quotient (ISQ) (Osstell AB, G€ oteborg, Sweden). These variables were evaluated for each implant in Groups A and B at T0 and T1.
Surgical and healing complications
Complications were evaluated for Groups A and B from T0 to T2. They were divided into surgical complications and healing complications, as suggested by Fontana et al. 2011 . 19 The former complications were classified as:
Class A, including flap damage (soft tissue perforation or laceration), Class B, including neurological damage (paresthesia or disesthesia), and Class C, including vascular damage (hemorrhage).
The latter complications were divided into four classes, according to the presence and extent of exposure, as well as the presence of a purulent exudate.
Class I: membrane exposure 3 mm, no purulent exudate.
Class II: membrane exposure 3 mm, no purulent exudate.
Class III: membrane exposure, with purulent exudate.
Class IV: abscess, without membrane exposure.
Healing complications were also divided into major or minor, depending on the influence on newly formed bone, according to Merli et al 2007.
14 Peri-implant bone defects and vertical bone gain A peri-implant bone defect was defined as the vertical distance between the top of the implant shoulder and the first visible boneimplant contact. It was recorded during T0 to assess the initial peri-implant bone defect (IBD) and during T1 to assess the "final" periimplant bone defect (FBD). These variables were assessed at four sites (mesial, distal, buccal, and lingual) around each implant using a University of North Carolina (UNC)-15 periodontal probe with a 1-mm graduated scale, rounding values to the nearest 0.5 mm. Implants were used as reference point for direct measurements of bone augmentation before and after surgery.
The vertical bone gain (VBG) was calculated as the difference between the FBD and IBD at the four sites (mesial, distal, buccal, and lingual) for each implant. It was expressed in millimeters (mm). We used a data collection form and data management system using Excel (Microsoft Excel 2011; Windows, ver. 14.0.0). Data were entered by a blinded operator. Before entry, data were evaluated for accuracy and completeness; logical consistency was verified, and the ranges of quantitative data were computed. Data were analyzed using the SPSS software (ver. 8.11.5; SPSS, Inc, Chicago, Illinois).
Statistical analysis
The power-analysis showed that with a minimum of 17 patients per group (total of 34 patients), it will be possible to detect a 35% difference in complications and a difference of 1 mm in VBG between the two groups with a standard deviation r 51 and a significance level of a 5 0.05 with a power of 80%. To protect from possible drop-outs, the sample size was increased by to 20 patients per group (total of 40 patients).
The results obtained in the two study groups (Groups A and B)
were subjected to statistical description and analyses using specific tests to determine statistically significant differences between them.
Both the intent-to-treat and per-protocol populations were analyzed.
The patient was regarded as the statistical unit of analysis for all analyses, except that of implant stability, which was carried out considering the implant as the statistical unit. Statistical differences in complication rates were investigated using Fisher's exact test. Differences in implant stability, peri-implant bone defects, and VBG at T0 and T1 were investigated using t-tests for unpaired data. Statistical significance was set at a 5 0.05. The statistician was blinded and external to working group.
| RE S U LTS

| Intent-to-treat population
In total, 40 patients (13 males, 27 females) with a mean age of 52 years were treated according to the protocol described previously. All patients underwent bone augmentation surgery and received 108 implants to restore posterior regions of the mandible. All implants were placed simultaneously with guided bone regeneration (GBR) proce- There was no statistically significant difference between Groups A and B regarding primary implant stability (P > .05).
At reopening surgery (T1), all implants (n 5 99, 100%) showed successful osseointegration after the submerged healing period. Reverse torque at 25 Ncm was used to assess adequate osseointegration.
Mean RFA values at reopening surgery were 71.0 6 8.0 ISQ and 66.5 6 10.0 ISQ in Groups A and B, respectively.
| Surgical complications
After the implant and bone augmentation surgeries (T0), four surgical complications occurred in four different patients. All these complica- The difference in the surgical complication rates between Groups A and B was not statistically significant (P 5 .34).
| Healing complications
In total, 7 complications occurred in 39 patients during the healing period (T0-T1). In Group A, three healing complications were observed, yielding an overall complication rate of 15.0% (n 5 3/20). Of these, two complications (Classes III and IV) affected the amount of newly formed bone or the success of the bone augmentation surgery and were, therefore, classified as major complications. One complication (Class II) did not affect the amount of newly formed bone and was, therefore, classified as a minor complication. In Group A, the rates of major and minor healing complications were 10.0% and 5%, respectively. Table 1 provides a description of the healing complications in Group A.
In Group B, four cases of healing complications were observed, yielding an overall complication rate of 21.1% (n 5 4/19). Of these, three (Class III and IV) were classified as major complications, whereas one (Class II) was classified as a minor complication. In Group B, the rates of major and minor healing complication were 15.8% and 5.3%, respectively. Table 2 provides a description of the healing complications in Group B.
No statistically significant difference was observed between
Groups A and B regarding the overall healing complication rates (P 5 .69) or the major or minor healing complication rate (P 5 .99).
| Peri-implant bone defect and vertical bone gain
Mean values of peri-implant bone defects (IBD and FDB) and vertical bone gain (VBG) in the two groups are presented in Tables 3 and 4 . In 
| DI SCUS SION
Many studies have demonstrated high success rates with dental implants in terms of both function and esthetics. [27] [28] [29] [30] [31] However, edentulous areas are often characterized by alveolar bone atrophy due to the continued bone resorption that occurs after tooth loss.
1,2,4
Although many studies have confirmed the reliability of short and ultrashort implants in atrophic mandibles and maxillae, 32,33 a threedimensional reconstruction of alveolar bone is often required to provide an esthetic and functional restoration. 34, 35 It was reported that the mean vertical dimensions of a partially edentulous posterior mandible from the IAN to the edge of the bone crest were 8.7 6 5.6 mm and 9.2 6 3.8 mm for the first and second molar areas, respectively.
36
. The horizontal dimensions were 6.6 6 3.0 mm and 6.9 6 3.2 for the first and second molar areas, respectively. 37 Because the presence of the inferior alveolar nerve requires a "safety zone" of at least 1-2 mm 38 and the resorption pattern in the retroforaminal area is vertical and centrifugal, 3,4 most long-term edentulous patients do not have adequate bone volumes to place standard or short implants. 36, 37, 39 Consequently, the posterior mandible is a challenging area that typically requires bone augmentation during or before implant surgery. 35 In this study, guided bone regeneration (GBR) using d-PTFE Tireinforced membranes or Ti mesh covered with collagen membranes was used to achieve an adequate implant-prosthetic restoration.
Because this procedure is still considered to be highly techniquesensitive and not free of complications that can affect the amount of newly formed bone and the success rate of the treatment, Fontana et al.
in 2011 19 suggested a classification of surgical and healing complications and recommended that these be managed differently according to class.
To date, there have been many reports regarding complication rates, vertical bone gain (VBG), and success rates after bone augmentation with PTFE membranes and Ti mesh. 40, 41 However, there have not been randomized clinical studies comparing the clinical outcomes of these two approaches.
If a membrane or mesh remains submerged completely for at least 6-9 months of uneventful healing, it is possible to achieve complete bone formation under the barrier device. However, if the membrane or mesh suffers early or late exposure, the amount of newly formed bone under the barrier could be affected negatively. Consequences of barrier exposure range from incomplete bone growth to failure of the entire regenerative surgery. 19 The main cause of GBR failure is related to early or late exposure of the barrier device, leading to contamination and infection of the biomaterials, irreversibly compromising bone regeneration. [16] [17] [18] [42] [43] [44] Other complications, such as the onset of an abscess with purulent exudate, can also lead to a complete failure of GBR even without exposure of the membrane. 19 In this study, healing complications in Group A were limited to one case of early membrane exposure with infection, one abscess without exposure, and one case of late membrane exposure without infection.
The first two were considered major complications because they resulted in the failure of the entire regenerative and implant surgery: all In terms of Ti mesh, a positive association of time and extent of device exposure with newly formed bone resorption has been established. 44 In the case of Ti mesh exposure, the lack of bone volume was significantly positively correlated with the area of mesh exposed, with a 16.3% deficit in bone volume for every cm 2 of mesh exposed. Additionally, there were positive associations of the lack of bone volume and early exposure with planned bone volume. 44 In this study, the surgical complications involved one case of temporary paresthesia for d-PTFE membranes and three for Ti mesh plus collagen membranes, yielding rates of 5% and 15.8%, respectively. This difference was not statistically significant. All surgical complications belonged to Class B 19 and recovered within 1 month after GBR surgery. These nerve injuries were probably caused by stretching of the mental nerve during flap passivation. Moreover, this class of complication is often related to the need for extensive flap management to achieve a tension-free closure over the barrier device. 12, 13, 19 Another cause of nerve injuries involves management of the barrier device: during bone augmentation surgery, d-PTFE membranes were shaped, adapted, and stabilized more readily and quickly than were the Ti mesh devices. Additionally, during the reopening surgery, Ti mesh required more time and more effort than did the non-resorbable membranes.
Thus, the latter showed better manageability and ease of use and required less dexterity and fewer manual skills.
Regarding VBG, the effectiveness of GBR for the resolution of vertical and horizontal bone defects has been demonstrated in short-and long-term studies. 5, 19, 43, 48 We showed mean bone gains of 4.2 and In this study, implants in both groups showed high IT and RFA torque values, probably due to the implant characteristics: specifically, the double-variable thread design. In atrophic posterior mandibles, the stabilization of implants can be difficult because of the reduced bone volume available above the mandibular canal.
Implant placement occurred simultaneously with bone augmentation, whereas and functional loading was delayed until 3-4 months after reopening surgery.
Loading was scheduled to occur after the soft tissues had completely healed following the connective tissue graft 53 and was timed to progressively modify the occlusal and lateral contacts of the definitive prosthesis. 12, 13, 20 Some authors have recommended delayed implant placement to allow better osseointegration and bone maturation. 25 Others have suggested delaying implant placement and then immediately loading the implants after bone augmentation. 21 Importantly, all "lost" implants were removed because of GBR failures. No implant placed using a simultaneous approach failed to osseointegrate.
Formation of an abscess without barrier device exposure in the surgical area generally leads to the total failure of a GBR procedure and the consequent failure of the implants. Removal of the barrier device with complete curettage of the area and systemic antibiotic therapy is immediately required. 19 Consistent with the literature, 19 in this study, abscess formation in both groups occurred during the first postoperative month, probably due to bacterial contamination of the barrier device during membrane handling or bacterial contamination of the graft. Regarding vertical bone augmentation procedures, the stability of the regenerated bone has been debated. Some authors have demonstrated that regenerated bone responds favorably under functional loading and shows stability over time. 7, 12, 46, [54] [55] [56] [57] The preliminary results of this study do not permit us to draw a conclusion in this regard. A longer follow-up period after the definitive loading is needed to observe any significant difference between d-PTFE membranes and Ti mesh plus collagen membranes with regard to peri-implant bone stability and crestal bone loss.
| CON CLU S I ON S
The preliminary results of this randomized controlled trial showed that d-PTFE membranes and titanium mesh plus collagen membranes produced similar results in terms of healing complication types and rates.
In contrast, d-PTFE membranes showed a lower rate of surgical complications. In both groups, similar vertical bone gain (VBG) and bone formation were achieved, with no complications occurring, confirming the reliability and effectiveness of guided bone regeneration (GBR) for restoring the atrophic posterior mandible. Finally, the use of doublevariable tapered implants seemed to be reliable in both immediate GBR approaches.
